Hypertension is one of the most common cardiovascular co-morbidities after successful
kidney transplantation. It commonly occurs in patients with other metabolic diseases, such …

Supported by several high-quality randomized controlled trials and registry analyses,
catheter-based renal denervation is becoming an important adjunctive treatment modality for …

Background Hypertension (HTN) is common following renal transplantation and it is
associated with adverse effects on cardiovascular (CV) and graft health. Ambulatory blood …

Background. Cardiovascular disease is a frequent complication after kidney transplantation
and represents the leading cause of mortality in this population. Material and Methods. We …

This systematic review and meta-analysis was conducted to assess the randomized
controlled trial (RCT) evidence available for renal denervation (RDN) in uncontrolled arterial …

Background. Normalization of arterial pressure occurs in just a few patients with
hypertensive chronic kidney disease undergoing kidney transplantation. Hypertension in …

Cardiovascular disease is the leading cause of death in patients with chronic renal disease
and the most common cause of death and allograft loss among kidney transplant recipients …

Renal denervation (RDN) is a catheter-based ablation procedure designed to treat resistant
hypertension (RH). The objective of our study is to determine the effect of RDN on blood …

Although kidney transplantation (KT) is the best treatment option for most patients with end-
stage kidney disease (ESKD) due to reduced mortality, morbidity and increased quality of …

Abstract Purpose of Review To incorporate novel findings on pathophysiology and treatment
of posttransplant hypertension. Recent Findings (1) The sodium retaining effects of CNIs are …